(19)
(11) EP 1 507 793 A2

(12)

(88) Date of publication A3:
27.05.2004

(43) Date of publication:
23.02.2005 Bulletin 2005/08

(21) Application number: 02786413.1

(22) Date of filing: 16.10.2002
(51) International Patent Classification (IPC)7C07K 2/00, C07K 14/00, C07K 14/52, A61K 38/16
(86) International application number:
PCT/US2002/032910
(87) International publication number:
WO 2003/033658 (24.04.2003 Gazette 2003/17)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

(30) Priority: 17.10.2001 US 329508 P
18.10.2001 US 329747 P
31.10.2001 US 330835 P
16.11.2001 US 331478 P
07.12.2001 US 336726 P
01.04.2002 US 368548 P

(71) Applicant: Human Genome Sciences, Inc.
Rockville, MD 20850 (US)

(72) Inventors:
  • YU, Guo-Liang
    Berkeley, CA 94705 (US)
  • EBNER, Reinhard
    Gaithersburg, MD 20878 (US)
  • NI, Jian
    Germantown, MD 20874 (US)
  • ROSEN, Craig, A.
    Laytonsville, MD 20882 (US)
  • LAIRD, Michael, W.
    Germantown, MD 20874 (US)
  • ULLRICH, Stephen
    Rockville, MD 20853 (US)

(74) Representative: VOSSIUS & PARTNER 
Siebertstrasse 4
81675 München
81675 München (DE)

   


(54) NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT